The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday. In clinical trials, the drug nearly eliminated HIV’s spread among ...

A generation has passed since the world saw the peak in AIDS-related deaths. Those deaths — agonizing, from diseases or infections the body might otherwise fight off — sent loved ones into the streets ...

Wesley Sundquist, PhD, Samuels Professor and chair of biochemistry at the University of Utah, laid the foundation for the development of a highly effective, long-lasting prophylactic against HIV, ...

A new pre-exposure prophylaxis (PrEP) drug has shown promise as a once-monthly oral pill to help prevent HIV. PrEP plays a key part in reducing the number of new HIV infections by stopping the virus ...

Drug-related problems in HIV treatment are prevalent, affecting treatment effectiveness and safety, with 99.7% of patients experiencing at least one DRP. Treatment safety was the most frequent problem ...

A previous post reviewed data about drug use among sexual and gender minority people. In addition to its direct health risks, drug use is associated with an increased risk of HIV infection. It might ...

Forbes contributors publish independent expert analyses and insights. Dr. Omer Awan is a practicing physician who covers public health. A twice-yearly injection of a drug known as lenacapavir offered ...

HIV-1 protease is a critical enzyme in the viral life cycle, facilitating the maturation of infectious viral particles by cleaving precursor polyproteins. The emergence of drug resistance, driven by ...